Literature DB >> 63691

Tranexamic acid and arterial thrombosis.

D Davies, D A Howell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 63691     DOI: 10.1016/s0140-6736(77)91690-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Efficacy of combined use of intraarticular and intravenous tranexamic acid in total knee arthroplasty.

Authors:  Daniel R Whiting; Rafael J Sierra
Journal:  Ann Transl Med       Date:  2015-05

Review 2.  A risk-benefit assessment of aprotinin in cardiac surgical procedures.

Authors:  W B Dobkowski; J M Murkin
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

Review 3.  Antifibrinolytic agents in subarachnoid haemorrhage.

Authors:  K W Lindsay
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

4.  Treatment of hereditary angioedema.

Authors:  B Marasini; M Cicardi; G C Martignoni; A Agostoni
Journal:  Klin Wochenschr       Date:  1978-08-15

Review 5.  Clinical pharmacology of aminocaproic and tranexamic acids.

Authors:  I M Nilsson
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

Review 6.  Inhibitors of fibrinolysis in the treatment of haemophilia.

Authors:  C R Rizza
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

Review 7.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

Review 8.  Tranexamic acid: a review of its use in surgery and other indications.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

9.  Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.

Authors:  H Fodstad
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

10.  Spontaneous thrombosis of ruptured intracranial aneurysms during treatment with tranexamic acid (AMCA). Report of three cases.

Authors:  H Fodstad; B Liliequist
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.